|
| DRUG REVIEW |
|
| Year : 2008 | Volume
: 54
| Issue : 1 | Page : 45-48 |
Ramelteon: A melatonin receptor agonist for the treatment of insomnia
V Devi, PK Shankar
Department of Pharmacology, Melaka Manipal Medical College, Manipal, India
Correspondence Address:
V Devi
Department of Pharmacology, Melaka Manipal Medical College, Manipal
India
 Source of Support: Nil, Conflict of Interest: Nil  | Check |
DOI: 10.4103/0022-3859.39193
Clinical trial registration Nil
Ramelteon is a novel MT1 and MT2 melatonin receptor selective agonist recently approved for the treatment of insomnia characterized by difficulty in sleep onset. It is a nonscheduled drug since it lacks the potential for abuse and does not interact with neurotransmitter receptors most associated with these phenomena. Although the effects of ramelteon use >5 weeks are unknown, the available data confirms its safety and efficacy for short-term use. Clinical use and future research should uncover more information about ramelteon's properties.
[FULL TEXT] [PDF]*
|
